SAVE THE DATE:
Cool Comedy • Hot Cuisine
Wednesday, November 12, 2025
The Edison Ballroom, New York City
Mark your calendar for a night to remember.
Join us on Wednesday, November 12, 2025, at the Edison Ballroom in New York City for our signature fundraising event, Cool Comedy • Hot Cuisine—hosted by the SRF, in proud partnership with the New York Comedy Festival.
This unforgettable evening brings together world-class performers, side-splitting laughter, and a gourmet experience—all to support the most promising and innovative research aimed at finding a cure.
Every laugh, every donation, and every person in the room helps us move closer to a world without scleroderma and to improving the lives of everyone affected by this disease.
Event Co-Chairs: Susan Feniger*, Regina Hall*, Caroline Hirsch, and Kelly Rizzo
*Scleroderma Research Foundation Board Member
Scenes from Cool Comedy • Hot Cuisine 2023, hosted by Jeff Ross, at the Edison Ballroom in New York City
2025 Talent Lineup to be announced.
Table Sponsorships Available Now!
(Individual tickets will be available this summer.)
For questions or more information, contact Anoushka Donnelley, Director of Philanthropy: anoushka@sclerodermaresearch.org
The History and Impact of CCHC
Since its inception in 1987, Cool Comedy • Hot Cuisine (CCHC) has become the Scleroderma Research Foundation’s (SRF’s) signature fundraising event, raising more than $29 million to fund the most promising scleroderma research.
Hosted for many years by SRF Board Members Bob Saget and Susan Feniger (pictured here in 2019), some of the world’s greatest comedians and performing artists donated their time and talents to support the SRF’s innovative research programs and help raise awareness about this rare autoimmune disease. Though devastated by the loss of Bob Saget in 2022, the SRF, in collaboration with his family and friends, will continue this event in the hopes of achieving Bob’s dream of ending scleroderma.
All funds raised directly support our research and patient education programs. The SRF is singularly focused on finding a cure, which is why we’ve invested more money in scleroderma research than any other nonprofit on earth.
